196 related articles for article (PubMed ID: 24144746)
1. [Correlation between serum marker variations and pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Xie X; Wang X; Zhang Y; Han D; Li S; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1458-62. PubMed ID: 24144746
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Jiang YW; Pang L; Fang QH; Ma YM
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
4. COPD and cardiac death: pressure (NT-proBNP), inflammation (CRP) or both?
Colice GL
Respiration; 2010; 79(5):353-4. PubMed ID: 20110653
[No Abstract] [Full Text] [Related]
5. High levels of interleukin-6 and 8-iso-prostaglandin in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension.
He H; Tao Y; Chen X; Qiu H; Zhu J; Zhang J; Ma H
Chin Med J (Engl); 2014; 127(9):1608-12. PubMed ID: 24791862
[TBL] [Abstract][Full Text] [Related]
6. Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension.
Rahimi-Rad MH; Rahimi P; Rahimi B; Gholamnaghad M
Pneumologia; 2014; 63(3):164-6. PubMed ID: 25420291
[TBL] [Abstract][Full Text] [Related]
7. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
8. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide is a prognostic parameter in chronic lung disease.
Leuchte HH; Baumgartner RA; Nounou ME; Vogeser M; Neurohr C; Trautnitz M; Behr J
Am J Respir Crit Care Med; 2006 Apr; 173(7):744-50. PubMed ID: 16415273
[TBL] [Abstract][Full Text] [Related]
10. Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Kwon YS; Chi SY; Shin HJ; Kim EY; Yoon BK; Ban HJ; Oh IJ; Kim KS; Kim YC; Lim SC
J Korean Med Sci; 2010 Oct; 25(10):1487-91. PubMed ID: 20890431
[TBL] [Abstract][Full Text] [Related]
11. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension.
Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP
Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853
[TBL] [Abstract][Full Text] [Related]
12. Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension.
Carratu P; Scoditti C; Maniscalco M; Seccia TM; Di Gioia G; Gadaleta F; Cardone RA; Dragonieri S; Pierucci P; Spanevello A; Resta O
BMC Pulm Med; 2008 Sep; 8():20. PubMed ID: 18822124
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus.
Tanaseanu C; Tudor S; Tamsulea I; Marta D; Manea G; Moldoveanu E
Eur J Med Res; 2007 Apr; 12(4):145-51. PubMed ID: 17509958
[TBL] [Abstract][Full Text] [Related]
14. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension.
Parola D; Romani S; Petroianni A; Locorriere L; Terzano C
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):183-91. PubMed ID: 22428469
[TBL] [Abstract][Full Text] [Related]
16. Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism.
Jin G; Chen Z; Zhang J; Song J; Shi J; Zhou B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217946
[No Abstract] [Full Text] [Related]
17. [Biomarkers of systemic inflammation, oxidative stress and their interactions in patients with combined flow of chronic obstructive pulmonary disease and arterial hypertension].
Kryvenko V
Georgian Med News; 2013 Mar; (216):23-8. PubMed ID: 23567304
[TBL] [Abstract][Full Text] [Related]
18. [Serum myostatin levels and malnutrition in patients with chronic obstructive pulmonary disease].
Ju CR; Chen RC
Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):465-8. PubMed ID: 21781527
[TBL] [Abstract][Full Text] [Related]
19. The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates.
Kubánek M; Málek I; Kautzner J; Hegarová M; Wiendl M; Lupínek P; Karasová L; Lánská V
Eur J Heart Fail; 2005 Dec; 7(7):1149-55. PubMed ID: 15916922
[TBL] [Abstract][Full Text] [Related]
20. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
